Bishengyuan (00926.HK) granted a total of 122.26 million share options
Gelonghui, May 8, 丨 Bishengyuan (00926.HK) announced that on May 8, 2024, the company granted a total of 122.26 million share options (subject to acceptance by the grantor) to 16 eligible participants in accordance with the terms of the plan.
Bishengyuan (00926.HK) grants 122.26 million share options
Bishengyuan (00926.HK) announced that on May 8, 2024, the company granted a total of 122.26 million share options (subject to acceptance by the grantor) to 16 eligible participants in accordance with the terms of the share option plan. The grantor can exercise the share options to subscribe for one share at the exercise price of HK$2.822 per share.
Bishengyuan (00926) grants 122.26 million share options
Bishengyuan (00926) announced that on May 8, 2024, the company awarded 16 companies in accordance with the terms of the share option plan...
碧生源:二零二三年年報
Besunyen Holdings' 2023 Loss Widens on Lower Revenue
Besunyen Holdings' (HKG:0926) attributable loss widened to 299.2 million yuan, or 2.45 yuan per share, in 2023, from 99.1 million yuan, or 1.76 yuan per share, in 2022, according to a filing with the
Bishengyuan (00926.HK)'s 2023 continuing operating revenue of 543 million yuan decreased by 32.2% year-on-year
Gelonghui, March 8, 丨 Bishengyuan (00926.HK) announced that in 2023, the Group's revenue from continuing operations was RMB 543 million, a decrease of 32.2% over the previous year. The total overall loss due to company owners in 2023 was RMB 300 million; basic and diluted losses per share attributable to company owners in 2023 were RMB 2.45. The Board of Directors has resolved not to declare and pay a final dividend for the year ended 31 December 2023. In 2024, the Group will actively embrace market changes and continue to promote Bishengyuan brand building and rejuvenation. Use multi-channel marketing strategies to improve
BESUNYEN: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Bishengyuan (00926.HK) proposes to adopt a share option plan
Gelonghui, March 8, 丨 Bishengyuan (00926.HK) announced that on March 8, 2024, the board of directors of the company approved the proposal to adopt a share option plan. The plan will constitute a share plan under Chapter 17 of the Hong Kong Stock Exchange Limited Securities Listing Rules.
Bishengyuan (00926.HK) held a board meeting on March 8 to consider and approve the annual results
GLONGHUI, Feb. 26 | Bishengyuan (00926.HK) announced that it will hold a board meeting on March 8, 2024 (Friday) to consider and approve the annual results of the company and its subsidiaries for the year ended 31 December 2023, and to consider proposals to declare and pay a final dividend (if any).
Bishengyuan (00926.HK) appoints Yu Hongjiang as company secretary, authorized representative and agent for legal process documents
Gelonghui November 23丨Bi Shengyuan (00926.HK) announced that Gu Liming has resigned as the company secretary of the company, authorized representative (“authorized representative”) as stipulated in section 3.05 of the Hong Kong Stock Exchange Limited stock listing rules, and authorized person representing the company under section 19.05 (2) of the listing rules for accepting documents and notices in Hong Kong (“legal procedure document agent”), effective from November 23, 2023. The board of directors also announced that Yu Hongjiang has been appointed as company secretary, authorized representative and agent for legal process documents since 2023/11
Besunyen Warns of Loss, Revenue Slump in Full Year 2023
Besunyen Holdings (HKG:0926) said it may record an attributable loss of between 237.5 million yuan and 277.5 million yuan for the year ending Dec. 31. Annual revenue is also likely to decline by 30% t
Bishengyuan (00926.HK): Expected annual net loss of about 237.5 million yuan - 277.5 million yuan
Glonghui, Oct. 20, 丨 Bishengyuan (00926.HK) announced that the Group's revenue for the year ending December 31, 2023 will be reduced by about 30% to 40% compared to 2022, and it is likely to record net losses attributable to shareholders of approximately RMB 237.5 million to RMB 277.5 million for the year ending December 31, 2023 (these estimated amounts do not take into account long-term asset impairment tests and possible impairment losses caused by changes in the fair value of shares of unlisted companies invested by the Group). Except that the company's 2023 interim report, which is dated August 28, 2023, has been disclosed
Besunyen Holdings Invests HK$100 Million in Open-Ended Fund
Therapeutic tea maker Besunyen Holdings (HKG:0926) has signed and submitted an application form, to the Central China Dragon Global Opportunity Fund SPC, to subscribe to HK$100 million worth of partic
Bishengyuan (00926.HK) has signed and submitted the subscription application form to the trustee
Glonghui, October 5, 丨 Bishengyuan (00926.HK) announced that on October 5, 2023, the company had signed and submitted a subscription application form to the trustee in connection with the HK$100 million subscription for fund shares. According to the contract documents, the independent portfolio period begins on October 31, 2023.
Besunyen Invests HK$100 Million in Fund
Besunyen Holdings (HKG:0926) board has approved the subscription of 100,000 shares in Central China Dragon Global Opportunity Fund SP6 for HK$100 million. The segregated portfolio of the Central China
BESUNYEN: INTERIM REPORT 2023
Changes in Hong Kong stocks 丨 Bishengyuan rose more than 7%, the price was higher during the renewal phase, with a cumulative increase of 70% during the month
GLONGHUI September 20 | Bishengyuan (0926.HK) once again rose by more than 7%. The cumulative increase during the month reached 70%, reaching a record high of HK$5.3 in nearly 2 years. According to the news, GLP-1 weight loss drugs, represented by smeglutide, have continued to be popular recently. According to reports, orlistat, the only approved diet drug in China, is one of Bishengyuan's core products. It contributed 268 million yuan in revenue to the company in 2022, accounting for 28.4% of total revenue.
Bishengyuan (00926.HK)'s revenue in the first half of the year fell 15.1% to 343 million yuan
Glonghui, August 28, 丨Bishengyuan (00926.HK) announced its interim results. For the six months ended June 30, 2023, the Group's continuing operating revenue for the first half of 2023 was RMB 343.0 million, a decrease of 15.1% from the continuing operating revenue of RMB 403.8 million for the same period in 2022. The Group's gross profit from continuing operations for the first half of 2023 was RMB 222.2 million, a decrease of 8.3% from gross continuing operations of RMB 242.3 million for the same period in 2022. The Group's gross profit from continuing operations for the first half of 2023
Bishengyuan (00926) released interim results, with total losses attributable to shareholders of 116 million yuan
Bishengyuan (00926) announced its interim results for the six months ended June 30, 2023, and continued operating income...
BESUNYEN: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
No Data